RLMD
Relmada Therapeutics Inc.
$3.83
+$0.28(+7.89%)
33
Overall
40
Value
36
Tech
23
Quality
Market Cap
$50.78M
Volume
715.64K
52W Range
$0.24 - $5.12
Target Price
$9.00
EPS Estimates Overview
| Current Quarter | $-0.14 | Next Quarter | $NA |
| Current Year | $-0.65 | Next Year | $-0.81 |
| QoQ Growth | NaN% | YoY Growth | -24.6% |
| 3Y EPS CAGR | +28.2% | Target Price | $9.00 |
| Consensus | Buy | Upside | +135.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $3.83 | +7.9% | 715.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW